| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 08/17/2005 | CN1214789C Delta 9 tetrahydrocannabinol (delta 9 THC) solution metered dose inhalers and methods of use |
| 08/17/2005 | CN1214783C Method for producing controlled releasing drug formulation or its precursor, the drug formulation and the precursor |
| 08/16/2005 | US6930130 For use in therapy of schizophrenia, Parkinson's disease, and Alzheimer's disease |
| 08/16/2005 | US6930122 Use of N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3 -carboxamide, a salt thereof or a solvate thereof |
| 08/16/2005 | US6930118 3-Oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 08/16/2005 | US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 08/16/2005 | US6930112 Administering antagonist for n-methylaspartic acid or gamma-aminobutyric acid |
| 08/16/2005 | US6930110 Nitrogen compounds such as 5-chloro-4-{4-[4-(2,3-dihydrobenzo[1,4]dioxine-5-yl)-piperazine-1-yl]-butylamino}-2H-piridazin-3-one, used as anxiolytic and hypotensive agents; side effect reduction |
| 08/16/2005 | US6930109 Antidepressant azaheterocyclyl methyl derivatives of 7,8-dihydro-6H-5-oxa-1-aza-phenanthrene |
| 08/16/2005 | US6930108 Nitrogen compounds such as 2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one, used for prophylaxis of psoriasis, diabetes, alopecia, genetic, sexual, cardiovascular or genetic disorders |
| 08/16/2005 | US6930105 Tetracyclicazaindoles and indolines having 5-HT activity |
| 08/16/2005 | US6930104 beta -amyloid precursor protein secretory stimulators; treating neurodegenerative disorders; n-carbamoyl- quinoxaline or quinoline derivatives |
| 08/16/2005 | US6930101 Thiazolopyrimidines useful as TNFα inhibitors |
| 08/16/2005 | US6930100 Phosphate prodrugs of fluoroxindoles |
| 08/16/2005 | US6930088 Conformationally constrained backbone cyclized somatostatin analogs |
| 08/16/2005 | US6930085 G-type peptides to ameliorate atherosclerosis |
| 08/16/2005 | US6929919 Proteins related to schizophrenia and uses thereof |
| 08/16/2005 | US6929811 Active agent is selected from the group consisting of anabasine, anatabine, nomicotine, Yerbamate (Ilex paraguariensis) extract, and a liquid extract of tobacco; especially for treating psychological disorders |
| 08/16/2005 | US6929808 Isolating modulators of amyloid expression; obtain plant, extract proteins, incubate with chromatographic column, elute, recover preferential protein |
| 08/16/2005 | US6929805 For oral administration comprising an analgesic with rapid onset of action and at least one systemically acting analgesic with sustained action, such as a combination of benzocaine and acetylsalicylic acid (ASA) |
| 08/16/2005 | CA2355293C Microbiologically sound and stable solutions of gamma-hydroxybutyrate salt for the treatment of narcolepsy |
| 08/16/2005 | CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them |
| 08/16/2005 | CA2220438C (n-(pyridinylmethyl)-heterocyclic)ylideneamine compounds as nicotinic acetylcholine receptor binding agents |
| 08/16/2005 | CA2131350C Sustained release drug formulation containing a tramadol salt |
| 08/16/2005 | CA2094859C Anticonvulsant fructopyranose cyclic sulfites and sulfates |
| 08/16/2005 | CA2084075C The ciliary neurotrophic factor receptor |
| 08/11/2005 | WO2005073395A1 Method of examining ability to regulate the expression of neprilysin activity |
| 08/11/2005 | WO2005073220A1 Remedy for irritable bowel syndrome with diarrhea |
| 08/11/2005 | WO2004056795A8 A process for preparing duloxetine and intermediates for use therein |
| 08/11/2005 | WO2004042063A8 Pharmaceutical composition for preparing a medicine for treating and/or preventing a pathology related to an obsessive behaviour or obesity |
| 08/11/2005 | US20050177881 Using presence of allelic mutations in lysosomal acid lipase (LIPA) and cholesterol 25-hydroxylase (CH25H) as diagnostic indicator of nervous system disorders |
| 08/11/2005 | US20050176976 GABA a modulating neurosteroids |
| 08/11/2005 | US20050176964 Nicotinamide derivatives useful as p38 inhibitors |
| 08/11/2005 | US20050176944 Intracellular signaling polypeptide for identifying modulator for prevention and treatment cell proliferative, endocrine, autoimmune/inflammatory, neurological, gastrointestinal, reproductive, developmental, and vesicle trafficking disorders |
| 08/11/2005 | US20050176927 polynucleotides which identify and encode human secreted proteins (SECP); expression vectors, host cells, antibodies, agonists, and antagonists; drug screening; diagnosis |
| 08/11/2005 | US20050176828 Polyamine acylated with a hydrophobic acyl group, where acylation is by formation of either an amide or a sulfonamide linkage; antiproliferative agents; inhibition of cellular polyamine synthesis, even in the presence of exogenously supplied spermidine to inhibit cell growth and proliferation |
| 08/11/2005 | US20050176826 Use of asc-1 inhibitors to treat neurological and psychiatric disorders |
| 08/11/2005 | US20050176820 Oxygenated esters of 4-iodo phenylamino benzhydroxamic acids |
| 08/11/2005 | US20050176817 Anticancer agents; prevention of infections; autoimmune diseases;antiarthritic agents; cystic fibrosis |
| 08/11/2005 | US20050176816 Controlling infections; antiallergens; antiarthritic agents; cardiovascular disorders |
| 08/11/2005 | US20050176815 Malaria therapy |
| 08/11/2005 | US20050176813 Modulating the potassium ion channel activity of T-cells; autoimmune and inflammatory diseases such as multiple sclerosis, rheumatoid arthritis or transplant rejection; synthesis by reaction of an acetophenone such as khellinone with an aryl aldehyde |
| 08/11/2005 | US20050176803 Indole derivatives as anti-inflammatory agents |
| 08/11/2005 | US20050176800 Preterm labor, dysmenorrhea, asthma, hypertension, fertility disorder, sexual dysfunction, undesired blood clotting, bone disorders, preeclampsia or eclampsia, or an eosinophil disorder; use with phosphodiesterase inhibitors; e.g. 7-[(2R,3R)-3-Chloro-1-(4-hydroxynonyl)-pyrrolidin-2-yl]-hept-5-enoic acid |
| 08/11/2005 | US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176777 administering anabasine, anatabine, nornicotine and carriers, diluents or vehicles, for treatment drug abuse and dependence |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176765 For therapy of glaucoma, dementia such as Alzheimer's disease and vascular dementia, depression, attention deficit disorder, sleep disorder, schizophrenia, pain, ischemia; -[1-[1-(3-Thienoyl)piperidin-4-yl]piperidin-4-yl]-1,3-dihydro-2H-benzimidazol-2-one |
| 08/11/2005 | US20050176762 Tachykinin receptor subtypes NK3 and NK2 (NK neurokinin); various diseases including respiratory system disorders, autoimmune disorders, psychological disorders, skin disorders |
| 08/11/2005 | US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide |
| 08/11/2005 | US20050176759 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders |
| 08/11/2005 | US20050176756 Cholinergic ligands at the nicotinic acetylcholine receptors and modulators of the monoamine receptors and transporters; treating pain, neurodegeneration, inflammation, and drug or alcohol withdrawal symptoms; 3-benzimidazole, indole or triazole substituted |
| 08/11/2005 | US20050176746 Treating eating disorders and digestive disorders wth loperamide |
| 08/11/2005 | US20050176745 Based on spiro(1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine) ring; ligands for nicotinic acetylcholine receptors; Alzheimer's disease, cognitive or attention disorders, anxiety, depression, smoking cessation, neuroprotection, schizophrenia, analgesia, Tourette's and Parkinson's |
| 08/11/2005 | US20050176735 For use as anxiolytic, antiepileptic, sedative-hypnotic agents and skeletal muscle relaxants |
| 08/11/2005 | US20050176732 Enantiomers of 1-(4-chlorophenyl)phenylmethyl]-4-[(4-methylphenyl)sulfonyl]piperazine |
| 08/11/2005 | US20050176731 N-[5-({(2S)-3-[(4-{4-[(4-benzylpiperidin-1-yl)carbonyl]phenyl}cyclohexyl)amino]-2-hydroxypropyl}oxy)-2-hydroxyphenyl]methanesulfonamide; beta 3 receptors agonist; gastrointestinal diseases; antiobesity, antidiabetic, cicatrizing agents, tocolytics, dysmenorrhea, antiglaucomatous; amidation |
| 08/11/2005 | US20050176729 Indole derivatives useful for the treatment of CNS disorders |
| 08/11/2005 | US20050176724 2-Methyl-5-(2-{4-[3-(1-methylpiperidin-4-yl)benzyl]piperidin-1-yl}ethoxy)quinoline hydrochloride; antagonist of 5-serotonin (HT)1 type receptors;antidepressant and anxiolytic agent |
| 08/11/2005 | US20050176722 Piperazinylacylpiperidine derivatives, their preparation and therapeutic use thereof |
| 08/11/2005 | US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines |
| 08/11/2005 | US20050176720 Pharmaceutical composition for the treatment of CNS and other disorders |
| 08/11/2005 | US20050176715 Piperidine derivatives |
| 08/11/2005 | US20050176714 Pyridazine derivatives |
| 08/11/2005 | US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/11/2005 | US20050176711 Phthalazine derivatives for treating inflammatory diseases |
| 08/11/2005 | US20050176709 Selective NPY (Y5) antagonists |
| 08/11/2005 | US20050176708 Piperidine derivatives useful as modulators of chemokine receptor activity |
| 08/11/2005 | US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse |
| 08/11/2005 | US20050176704 Hydroxymorpholinone derivative and medicinal use thereof |
| 08/11/2005 | US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof |
| 08/11/2005 | US20050176694 steroids such as (11 beta )-11-17-dihydroxy-21-[N-acetyl-S-(4-nitroxybutyroyl) cisteinyloxy]pregne-1,4-diene-3,20-dione having antiinflammatory, immunodepressive and angiostatic activity |
| 08/11/2005 | US20050176687 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 08/11/2005 | US20050176671 Drug screening; competitive binding; antitumor agents, antiproliferative agents, as promoter providing neuronal cell growth, wound healing, and cerebral injury healing; receptor binding assay, gene expression |
| 08/11/2005 | US20050176661 Antiviral oligonucleotides |
| 08/11/2005 | US20050176639 Use of osteopontin for the treatment and/or prevention of neurologic diseases |
| 08/11/2005 | US20050176123 Protease inhibitor |
| 08/11/2005 | US20050176094 Polypeptide having immunomodulatory activity, antiviral activity, and antitumor activity; polynucleotides, expression vectors , probes and antibodies; predicting responsiveness to treatment with interferon- alpha and other interferons which act at the Type 1 interferon receptor |
| 08/11/2005 | US20050176060 Crystal structure |
| 08/11/2005 | US20050175763 Phosphatidyl serine, phosphatidyl choline and similar compounds; food for tube feeding; health-giving, performance-enhancing or disease-preventing (eg diabetes) |
| 08/11/2005 | US20050175706 Sustained release oral formulations |
| 08/11/2005 | US20050175692 Pharmaceutical formulation comprising melatonin |
| 08/11/2005 | US20050175691 Pramipexole once-daily dosage form |
| 08/11/2005 | US20050175676 Patch |
| 08/11/2005 | US20050175636 Containing stabilized neurotoxin as analgesic and skin penetration enhancing agent; inflammation and/or pain reduction |
| 08/11/2005 | CA2555367A1 Apoe genetic markers associated with age of onset of alzheimer's disease |
| 08/11/2005 | CA2554959A1 Combination of a nmda receptor antagonist and a mao-inhibitor or a gadpf-inhibitor for the treatment of central nervous system-related conditions |
| 08/11/2005 | CA2554749A1 P2x receptor inhibitor |
| 08/11/2005 | CA2554733A1 Method for producing sorbicillactone a |
| 08/11/2005 | CA2554461A1 Method for obtaining precursor z and use thereof for the production of a means for therapy of human molybdenum cofactor deficiency |
| 08/11/2005 | CA2554351A1 Cgrp receptor antagonists |
| 08/11/2005 | CA2553931A1 Erythrocyte function modifying substance |
| 08/11/2005 | CA2553084A1 Novel benzofuran derivative, medicinal composition containing the same, and uses of these |
| 08/10/2005 | EP1561807A1 Method of degrading hardly degradable protein |
| 08/10/2005 | EP1561751A1 Fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals |
| 08/10/2005 | EP1560837A2 Novel ampiphilic derivatives of alpha-c-phenyl n-tert-butyl nitrone |
| 08/10/2005 | EP1560835A1 Spirocyclic cyclohexane derivatives |
| 08/10/2005 | EP1560828A1 Imidazoquinoline derivatives as adenosine a3 receptor ligands |
| 08/10/2005 | EP1560825A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same |